[go: up one dir, main page]

GB0623381D0 - Use of a compound as VEGF inhibitor - Google Patents

Use of a compound as VEGF inhibitor

Info

Publication number
GB0623381D0
GB0623381D0 GBGB0623381.1A GB0623381A GB0623381D0 GB 0623381 D0 GB0623381 D0 GB 0623381D0 GB 0623381 A GB0623381 A GB 0623381A GB 0623381 D0 GB0623381 D0 GB 0623381D0
Authority
GB
United Kingdom
Prior art keywords
compound
vegf inhibitor
vegf
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623381.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AcurePharma AB
Original Assignee
AcurePharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AcurePharma AB filed Critical AcurePharma AB
Priority to GBGB0623381.1A priority Critical patent/GB0623381D0/en
Publication of GB0623381D0 publication Critical patent/GB0623381D0/en
Priority to PCT/EP2007/009767 priority patent/WO2008061647A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0623381.1A 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor Ceased GB0623381D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0623381.1A GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor
PCT/EP2007/009767 WO2008061647A1 (en) 2006-11-23 2007-11-12 Use of a compound as vegf inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623381.1A GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor

Publications (1)

Publication Number Publication Date
GB0623381D0 true GB0623381D0 (en) 2007-01-03

Family

ID=37636386

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623381.1A Ceased GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor

Country Status (2)

Country Link
GB (1) GB0623381D0 (en)
WO (1) WO2008061647A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010108503A1 (en) 2009-03-24 2010-09-30 Life & Brain Gmbh Promotion of neuronal integration in neural stem cell grafts
AU2010277356A1 (en) * 2009-07-31 2012-03-08 Anamar Ab Compounds for treatment of inflammation
DK3164123T3 (en) 2014-07-02 2020-08-03 Inflectis Bioscience Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
JP6621815B2 (en) * 2014-07-02 2019-12-18 インフレクティス・バイオサイエンス O-alkyl-benzylideneguanidine derivatives and therapeutic uses for the treatment of disorders associated with the accumulation of misfolded proteins
EP3790539A1 (en) 2018-05-09 2021-03-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
SE9604348D0 (en) * 1996-11-26 1996-11-26 Wapharm Ab Use of hydroxyguanidines
GB0019357D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines

Also Published As

Publication number Publication date
WO2008061647A8 (en) 2008-11-27
WO2008061647A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
GB0611405D0 (en) FKBP-L: A novel inhibitor of angiogenesis
PT2094708E (en) A pyrrolopyrazin as syk-kinase inhibitor
PL2402317T3 (en) DGAT inhibitor
PL2361922T3 (en) Intermediate to HCV-Nucleoside Inhibitors
SI2295410T1 (en) HDAC inhibitor
GB0621607D0 (en) Inhibitors of c-Met
ZA200808639B (en) Oxadiazolidinedione compound
IL196067A0 (en) New cxcr2 inhibitors
ZA200810025B (en) Cox-2 inhibitor
GB0602778D0 (en) Novel compound
PL1988081T3 (en) Binding inhibitor of sphingosine-1-phosphate
EP2050036A4 (en) Potentiation of antifungal compounds
GB0619325D0 (en) New compounds
EP2000469A4 (en) Acylaminopiperidine compound
EP2036894A4 (en) Aurora inhibitor
GB0607096D0 (en) Compound
GB0623381D0 (en) Use of a compound as VEGF inhibitor
IL205299A0 (en) Parp inhibitor compounds
GB0604142D0 (en) Compound
GB0625826D0 (en) New compounds
GB0625827D0 (en) New compounds
AP2717A (en) Mono-hydrochloric salts of an inhibitor of histonedeacetylase
HU0600920D0 (en) New compounds
GB0618263D0 (en) Compound
TWI316060B (en) Neuraminidase inhibitor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)